Exclusive access to monthly insights from the world’s most innovative cannabis
processor. Join over 7000+ subscribers world-wide.
Nextleaf Solutions, the world’s most innovative cannabis extractor, is pleased to provide shareholders with the following commercial update and comments on its second-quarter results:
Nextleaf Provides Commercial Update
Nextleaf is pleased to announce that subsequent to the quarter-end it completed the second wholesale order from its recently announced customer, a NASDAQ-listed global cannabis company (the “Partner”). The Company’s wholly-owned subsidiary Nextleaf Labs Ltd. (“Nextleaf Labs” or “Labs”) supplies the Partner with high-purity CBD distillate to power their branded CBD oil products that are distributed by provincially-authorized retailers across Canada.
Additionally, the Company is pleased to announce Nextleaf Labs has onboarded an Ontario licensed producer (the “New Partner”) and received an initial purchase order for approximately 40 kilos of high-purity THC distillate. The New Partner plans to use Nextleaf’s THC distillate to power their market-leading vape brand.
“We are thrilled that our two newest partners are leveraging Nextleaf’s competitive advantage to power their established brands,” said Nextleaf Solutions CEO Paul Pedersen. “We continue to expand our B2B wholesale business, supplying some of the world’s largest cannabis producers with THC and CBD oils produced by Nextleaf’s patented cannabis oil refinery. With the recent issuance of our sales amendment by Health Canada, Nextleaf looks forward to increasing revenues through the sale of branded consumer cannabis products by provincially-authorized retailers,” said Pedersen.
Q2 Highlights and Recent Developments
In the second quarter, Nextleaf Solutions continued to execute on its corporate strategy and advance its commercial operations, as illustrated by the following milestones:
Nextleaf Comments on Financial Results from Q2 Financials
The second quarter saw an increased operational focus on both finalization of Nextleaf’s sales amendment, which was received shortly after the quarter-end, and optimization and scaling of vape cartridge manufacturing line, capable of producing up to 8,000 vape cartridges per day. With capital expenditures tapering off significantly and overheads tightening, Nextleaf expects to be well positioned to grow its B2B segment, consistently as the overall market moves toward equilibrium.
“Beyond turning initial B2B orders into longer-term supply agreements, increased revenue optionality is key to building a sustainable business model. We’ve built a facility, team, and IP base that has synergies through all three of our revenue pillars of IP licensing, B2B bulk sales, and B2C branded product sales. We believe a diverse revenue model, with commonalties will allow us to build a very sustainable business in the medium term, while smoothing revenues as the B2B market normalizes,” said Nextleaf CFO Charles Ackerman. “Due to a focus on automation, as Nextleaf’s facility utilization increases – further operational synergies should be realized, providing the ability to drive costs down and provide more value to our partners,” said Ackerman.
For more information please contact:
604-283-2301 (ext. 219)
On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO
Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.
Exclusive access to monthly insights from Canada’s most innovative cannabis processor. Join over 7000+ subscribers world-wide!
By selecting yes, I certify that I am of legal age in my jurisdiction to consume cannabis.